海辰药业：公司甲硫酸新斯的明注射液获得药品注册批件

Core Viewpoint - The company has received approval from the National Medical Products Administration for the registration of a new drug, Methanesulfonic Acid Neostigmine Injection, indicating a significant advancement in its product portfolio [1] Group 1: Drug Approval Details - The drug is named Methanesulfonic Acid Neostigmine Injection, classified as a Class 3 chemical drug [1] - The approved specifications for the drug are 1ml:0.5mg, 2ml:1mg, and 4ml:2mg [1] - The registration approval numbers are National Drug Approval Code H20255920, H20255921, and H20255919, with the conclusion of approval for registration [1]